| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |